MEDS SEC Filings: 8-K, 10-Q, S-3 & 424B – DataMEDS AI

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 17, 2026

NT 10-Q

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Aug 14, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 19, 2026

NT 10-Q

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

May 15, 2026

10-K/A

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Apr 24, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 20, 2026

News

TYPE

HEADLINE

FILED AT

8-K

DataMEDS AI Terminates Second Amended and Restated Letter of Intent Due to Market Conditions

Nov 5, 2026

8-K

DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP for Telehealth and Medical Drones

Oct 26, 2026

8-K

Healthcare company Regains Nasdaq Equity Rule Compliance After Stockholders’ Equity Exceeds $2.5 Million, Though Ongoing Compliance Remains Required

Oct 20, 2026

8-K

DataMeds AI Enters Strategic IP License Agreement with REBOOT Health AI and Provides Nasdaq Listing Update

Oct 16, 2026

8-K

DataMEDS AI Resolves Legal Disputes, Extinguishes $19 Million in Liability, and Acquires Platform License

Oct 13, 2026

8-K

DataMEDS AI Enters Settlement Agreement to Resolve Litigation and Extinguish Liability

Sep 17, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B4

Sep 29, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 3,578,254

May 7, 2025

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Mar 6, 2025

424B4

Form 424B4 - Prospectus [Rule 424(b)(4)]

Feb 21, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-1/A

SHARE RESALE REGISTRATION | Shares: 34,462,057

Oct 9, 2026

S-1

SHARE RESALE REGISTRATION

Aug 7, 2026

DRS/A

Form DRS/A - Draft Registration Statement: [Amend]

Jun 10, 2026

S-3

April 2026 SHELF

Apr 15, 2026

DRS

Form DRS - Draft Registration Statement

Feb 11, 2026

S-1/A

SHARE RESALE REGISTRATION | Shares amount: 5,357,142 | Share price: $1.40 | Warrants amount: 5,357,142

Sep 19, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEF 14C

NEWForm DEF 14C - Other definitive information statements

Nov 9, 2026

PRE 14C

Form PRE 14C - Other preliminary information statements

Oct 13, 2026

PRE 14C

Form PRE 14C - Other preliminary information statements

Aug 31, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Jun 18, 2026

PRER14A

Form PRER14A - Preliminary Proxy Soliciting materials

May 15, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

May 4, 2026

Ownerships

TYPE

HEADLINE

FILED AT

AJJARAPU SURENDRA K (Reporting)

Jun 25, 2026

Patel Prashant (Reporting)

Jun 25, 2026

4/A

Patel Prashant (Reporting)

Jun 25, 2026

4/A

AJJARAPU SURENDRA K (Reporting)

Jun 25, 2026

Patel Prashant (Reporting)

Apr 23, 2026

AJJARAPU SURENDRA K (Reporting)

Apr 23, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

May 8, 2026

CORRESP

Form CORRESP - Correspondence

May 5, 2026

CORRESP

Form CORRESP - Correspondence

May 1, 2026

LETTER

Form UPLOAD - SEC-generated letter

Apr 23, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 26, 2025

CORRESP

Form CORRESP - Correspondence

Sep 23, 2025

DataMEDS AI, Inc. MEDS · SEC Filings